Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Lucid Diagnostics (LUCD) Return on Capital Employed (2021 - 2026)

Lucid Diagnostics filings provide 5 years of Return on Capital Employed readings, the most recent being 66.79% for Q4 2025.

  • On a quarterly basis, Return on Capital Employed rose 140337.0% to 66.79% in Q4 2025 year-over-year; TTM through Dec 2025 was 66.79%, a 140337.0% increase, with the full-year FY2025 number at 174.08%, up 66805.0% from a year prior.
  • Return on Capital Employed hit 66.79% in Q4 2025 for Lucid Diagnostics, up from 243.33% in the prior quarter.
  • In the past five years, Return on Capital Employed ranged from a high of 991.86% in Q1 2025 to a low of 5540.8% in Q4 2023.
  • Median Return on Capital Employed over the past 5 years was 260.61% (2024), compared with a mean of 593.34%.
  • Biggest five-year swings in Return on Capital Employed: crashed -533260bps in 2023 and later surged 407063bps in 2024.
  • Lucid Diagnostics' Return on Capital Employed stood at 101.98% in 2021, then plummeted by -104bps to 208.2% in 2022, then tumbled by -2561bps to 5540.8% in 2023, then soared by 73bps to 1470.17% in 2024, then surged by 95bps to 66.79% in 2025.
  • The last three reported values for Return on Capital Employed were 66.79% (Q4 2025), 243.33% (Q3 2025), and 760.17% (Q2 2025) per Business Quant data.